Irish pharmaceuticals group Uniphar has completed its acquisition of Durbin, a specialist pharmaceuticals provider based in the UK and the US.
Uniphar says Durbin will be integrated into its Product Access division, which will grow to more than 170 employees working out of offices in Ireland, the UK and the US.
"This acquisition is a key strategic milestone in expanding Uniphar's global footprint and is an important step towards achieving our ambition of becoming a global leader in the Product Access space," Uniphar CEO Ger Rabbette said today.
"Post the integration of Durbin, we believe that Uniphar will offer a compelling proposition to manufacturers seeking a commercial partner with global reach and scalable digital capabilities," he added.
Uniphar says the division will supply more than five million units to more than 160 countries annually, and will manage access programmes for 36 global manufacturers.
Leslie Morgan, CEO of Durbin, said: "Uniphar's e-Commerce platform and Patient Management System are highly complementary to our capabilities and were a key attraction for us in bringing the businesses together.
"Combining Durbin’s global sourcing and distribution platform as well as its regulatory and compliance expertise with Uniphar’s digital capabilities will greatly enhance the enlarged Group’s global ambitions within its Product Access division".